Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing
read more
News
Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals
Establishing a lead position in Taiwan’s CDMO sector
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market
Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics. Besides Bora, investors into the new entity include Taishin Healthcare Limited Partnership and Tanvex BioPharma founder Dr. Allen Chao. Bora also announced that they will initially...